Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation

Gene Therapy

Volumn 14, Issue 12, 2007, Pages 950-959

  Hojman, P ^a   Gissel, H ^b   Gehl, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXYCYCLINE; DRINKING WATER; ERYTHROPOIETIN; GREEN FLUORESCENT PROTEIN; HEMOGLOBIN; LUCIFERASE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROPORATION; FLUID INTAKE; GENE EXPRESSION; GENE INDUCTION; GENE TRANSFER; GENETIC TRANSFECTION; HEMATOCRIT; MOUSE; MUSCLE MASS; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GREEN FLUORESCENT PROTEINS; HEMOGLOBINS; IRON; LUCIFERASES; MALE; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; TRANSGENES;

EID: 34249863632     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302951     Document Type: Article

References (50)

1. Gehl J. Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
2. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilisation and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353-359.
3. Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D et al. Mechanisms of in vivo DNA electrotransfer: Respective contributions of cell electropermeabilisation and DNA electrophoresis. Mol Ther 2002; 5: 133-140.
4. Satkauskas S, Andre F, Bureau M, Scherman D, Miklavcic D, Mir LM. Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 2005; 16: 1194-1201.
5. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M et al. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13.
6. Gehl J, Geertsen PF. Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy. Eur J Cancer Suppl 2006; 4 35-37.
7. Mir LM. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 2006; 4: 38-44.
8. Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther 2006; 17: 890-897.
9. Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: A protein factory. Gene Therapy 2003; 10: 131-142.
10. Kreiss P, Bettan M, Crouzet J, Scherman D. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med 1999; 1: 245-250.
11. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999; 96: 6417-6422.
12. Payen E, Bettan M, Rouyer-Fessard P, Beuzard Y, Scherman D. Improvement of mouse [beta]-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol 2001; 29: 295-300.
13. Maruyama H, Sugawa M, Moriguchi Y, Imazeki I, Ishikawa Y, Ataka K et al. Continuous erythropoietin delivery by muscletargeted gene transfer using in vivo electroporation. Hum Gene Ther 2000; 11: 429-437.
14. Terada Y, Tanaka H, Okado T, Inoshita S, Kuwahara M, Akiba T et al. Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation. Am J Kidney Dis 2001; 38: S50-S53.
15. Muramatsu T, Arakawa S, Fukazawa K, Fujiwara Y, Yishida T, Sasaki R et al. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int J Mol Med 2001; 7: 37-42.
16. Maruyama H, Ataka K, Gejyo F, Higuchi N, Ito Y, Hirahara H et al. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Therapy 2001; 8: 461-468.
17. Ataka K, Maruyama H, Neichi T, Miyazaki J, Gejko F. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Am J Nephrol 2003; 23: 315-323.
18. Rizzuto G, CappellettiM, Mennuni C,Wiznerowicz M, DeMartis A, Maione D et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 11: 1891-1900.
19. Fattori E, Cappelletti M, Zampaglione I, Mennuni C, Calvaruso F, Arcuri M et al. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates. J Gene Med 2005; 7: 228-236.
20. Magnani M, Rossi L, Stocchi V, Cucchiarini L, Piacentini G, Fornaini G. Effect of age on some properties of mice erythrocytes. Mech Ageing Develop 1988; 42: 37-47.
21. Toniatti C, Bujard H, Cortese R, Ciliberto G. Gene therapy progress and prospects: Transcription regulatory systems. Gene Therapy 2004; 11: 649-657.
22. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
23. Perez N, Plence P, Millet V, Greuet D, Minot C, Noel D et al. Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther 2002; 13: 2161-2172.
24. Lamartina S, Roscilli G, Rinaudo CD, Sporeno E, Silvi L, Hillen W et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 2002; 13 199-210.
25. Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Joussemet B, Bujard H et al. Optimal design of a single recombinant adenoassociated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther 2004; 9: 410-418.
26. Miklavcic D, Semrov D, Mekid H, Mir LM. Avalidated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73-83.
27. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267.
28. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 1997; 3: 299-305.
29. Moller PH, Eriksen J, Gehl J. Tet-On induction with doxycycline after gene transfer in mice: Sweetening of drinking water is not a good idea. Anim Biotechnol. In press.
30. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371-387.
31. Mir LM, Gehl J, Sersa G, Collins CG, Garbay J, Billard V et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25.
32. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
33. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T et al. In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428: 233-240.
34. Samakoglu S, Fattori E, Lamartina S, Toniatti C, Stockholm D, Heard JM et al. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles. Blood 2001; 97: 2213-2220.
35. Durieux AC, Bonnefoy R, Freyssenet D. Kinetic of transgene expression after electrotransfer into skeletal muscle: Importance of promoter origin/strength. Biochim Biophys Acta 2005; 1725: 403-409.
36. Fabre E, Bigey P, Orsini C, Scherman D. Comparison of promoter region constructs for in vivo intramuscular expression. J Gene Med 2006; 8: 636-645.
37. Fisher JW. Erythropoietin: Physiology and pharmacology update. Exp Biol Med 2003; 228: 1-14.
38. Zhou HS, Liu DP, Liang CC. Challenges and strategies: The immune responses in gene therapy. Med Res Rev 2004; 24: 748-761.
39. Mathiesen I. Electropermeabilisation of skeletal muscle enhances gene transfer in vivo. Gene Therapy 1999; 6: 508-514.
40. Donà M, Sandri M, Rossini K, Dell'Aica I, Podhorska-Okolow V, Carraro U. Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem Biophys Res Com 2003; 312: 1132-1138.
41. Wang XD, Tang JG, Xie XL, Yang JC, Li S, Ji JG et al. A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. J Gene Med 2005; 7: 1235-1245.
42. Molnar MJ, Gilbert R, Lu Y, Liu AB, Guo A, Larochelle N et al. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Mol Ther 2004; 10: 447-455.
43. Hartikka J, Sukhu L, Buchner C, Hazard D, Bozoukova V, Margalith M et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4: 407-415.
44. Durieux A, Bonnefoy R, Busso T, Freyssenet D. In vivo gene electrotransfer into skeletal muscle: Effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 2004; 6: 809-816.
45. Wang M, Orsini C, Casanova D, Millan JL, Mahfoudi A, Thuillier V. MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice. Gene 2001; 279: 99-108.
46. Trochon-Joseph V, Martel-Renoir D, Mir LM, Thomaidis A, Opolon P, Connault E et al. Evidence of antiangiogeni and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res 2004; 64: 2062-2069.
47. Perez N, Bigey P, Scherman D, Danos O, Piechaczyk M, Pelegrin M. Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet Vaccines Ther 2004; 2: 2.
48. Bettan M, Emmanuel F, Darteil R, Caillaud JM, Soubrier F, Delaère P et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000; 2: 204-210.
49. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
50. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.